Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients
View ORCID ProfileMichael Hultström, View ORCID ProfileKarin Fromell, View ORCID ProfileAnders Larsson, View ORCID ProfileSusan E Quaggin, View ORCID ProfileChrister Betsholtz, View ORCID ProfileRobert Frithiof, View ORCID ProfileMiklos Lipcsey, View ORCID ProfileMarie Jeansson
doi: https://doi.org/10.1101/2021.01.13.21249429
Michael Hultström
1Anesthesia and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Sweden
2Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Sweden
Karin Fromell
3Department of Immunology, Genetics, and Pathology, Uppsala University, Sweden
Anders Larsson
4Department of Medical Sciences, Clinical Chemistry, Uppsala University, Sweden
Susan E Quaggin
5Feinberg Cardiovascular Research Institute, Northwestern University, Chicago, IL, USA
6Division of Nephrology and Hypertension, Northwestern University, Chicago, IL, USA
Christer Betsholtz
3Department of Immunology, Genetics, and Pathology, Uppsala University, Sweden
7Department for Medicine, Huddinge, Karolinska Institutet, Sweden
Robert Frithiof
1Anesthesia and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Sweden
Miklos Lipcsey
1Anesthesia and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Sweden
8Hedenstierna Laboratory, CIRRUS, Anesthesia and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Sweden
Marie Jeansson
3Department of Immunology, Genetics, and Pathology, Uppsala University, Sweden
7Department for Medicine, Huddinge, Karolinska Institutet, Sweden
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted January 15, 2021.
Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients
Michael Hultström, Karin Fromell, Anders Larsson, Susan E Quaggin, Christer Betsholtz, Robert Frithiof, Miklos Lipcsey, Marie Jeansson
medRxiv 2021.01.13.21249429; doi: https://doi.org/10.1101/2021.01.13.21249429
Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients
Michael Hultström, Karin Fromell, Anders Larsson, Susan E Quaggin, Christer Betsholtz, Robert Frithiof, Miklos Lipcsey, Marie Jeansson
medRxiv 2021.01.13.21249429; doi: https://doi.org/10.1101/2021.01.13.21249429
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)